Prof Steve Howell Joins the Board of Innova Biosciences
Feb 01, 2016
Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the appointment of Professor Steve Howell to the Board of Directors.
Steve, CEO of Innova Partnerships, commented; “Innova Biosciences’ world leading bioconjugation technology business is backed by a team of dedicated executives, scientists and customer service personnel. I am very pleased to be joining the Board, to help lead Innova through its next stages of development.”
Latest News
-
Biotangents; Primed for Success
- Oct 19, 2017 -
Dr Andrew McNair Appointed as Innova Partnerships Managing Director
- Jul 21, 2017 -
Innova Partnerships Exits Portfolio Company: Innova Biosciences Acquired by SYGNIS AG
- Jun 21, 2017 -
Portfolio Company, Relaymed, Signs Strategic Alliance with Siemens Healthineers to Seamlessly Deliver Point-of-Care Test Results to HER Systems
- May 18, 2017 -
Portfolio Company, Innova Biosciences, valued at €12.8 Million to be Acquired by Sygnis AG
- May 08, 2017